Abstract
The knowledge of the biology of head and neck squamous cell carcinoma (HNSCC) has had relatively little impact on the improvement in oncologic outcome up to date. However, the identification of oncogenes and tumor suppressor genes (TSGs) involved in cancer progression contributes to the understanding of the molecular pathways involved in oncogenesis and could contribute to individual risk assessment and provide tools for improvement of treatment and targets for therapy based on the alterations in these pathways. The aim of this article is to review the chromosomal aberrations commonly found in HNSCC, to identify the genes in these chromosomal regions suggested to act as (candidate) oncogenes or TSGs, and to discuss the molecular mechanisms modulating their expression.
Similar content being viewed by others
References
Braakhuis BJM, Brakenhoff RH, Leemans CR (2010) Gene expression profiling in head and neck squamous cell carcinoma. Curr Opin Otolaryngol Head Neck Surg 18:67–71
Lallemant B, Evrard A, Chambon G, Sabra O, Kacha S, Lallemant JG, Lumbroso S, Brouillet JP (2010) Gene expression profiling in head and neck squamous cell carcinoma: clinical perspectives. Head Neck 32:1712–1719
Sur I, Tuupanen S, Whitington T, Aaltonen LA, Taipale J (2013) Lessons from functional analysis of genome-wide association studies. Cancer Res 73:4180–4184
Reis-Filho J (2009) Next-generation sequencing. Breast Cancer Res 11(suppl 3):S12
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674
Basil CF, Zhao Y, Zavaglia K, Jin P, Panelli MC, Voiculescu S, Mandruzzato S, Lee HM, Seliger B, Freedman RS, Taylor PR, Hu N, Zanovello P, Marincola FM, Wang E (2006) Common cancer biomarkers. Cancer Res 66:2953–2961
Leemans CR, Braakhuis BJM, Brakenhoff RH (2011) The molecular biology of head and neck cancer. Nat Rev Cancer 11:9–22
El-Naggar AK, Mao L, Staerkel G, Coombes MM, Tucker SL, Luna MA, Clayman GL, Lippman S, Goepfert H (2001) Genetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screening. J Mol Diagn 3:164–170
Huang Q, Yu GP, McCormick SA, Mo J, Datta B, Mahimkar M, Lazarus P, Schäffer AA, Desper R, Schantz SP (2002) Genomic differences detected by comparative genetic hybridization in head and neck squamous cell carcinoma from different tumor sites. Constructions of oncogenetic trees for tumor progression. Gene Chromosomes Cancer 34:224–233
Shiomi H, Sugihara H, Kamitani S, Tokugawa T, Tsubosa Y, Okada K, Tamura H, Tani T, Kodama M, Hattori T (2003) Cytogenetic heterogeneity and progression of esophageal squamous cell carcinoma. Cancer Genet Cytogenet 147:50–61
Hunt JL, Barnes L, Lewis JS Jr, Mahfouz ME, Slootweg PJ, Thompson LDR, Cardesa A, Devaney KO, Gnepp DR, Westra WH, Rodrigo JP, Woolgar JA, Rinaldo A, Triantafyllou A, Takes RP, Ferlito A (2014) Molecular diagnostic alterations in squamous cell carcinoma of the head and neck and potential diagnostic applications. Eur Arch Otorhinolaryngol 271:211–223
Jones AS (2000) Tumor suppressor genes and head and neck cancer. In: Kitamura K, Steel KP (eds) Genetics in Otolaryngology, vol 56. Karger, Basel, pp 249–260
Payne SR, Kemp CJ (2005) Tumor suppressor genetics. Carcinogenesis 26:2031–2045
Rodrigo JP, García-Pedrero JM, Suárez C, Takes RP, Thompson LDR, Slootweg PJ, Woolgar JA, Westra WH, Brakenhoff RD, Rinaldo A, Devaney KO, Williams MD, Gnepp DR, Ferlito A (2012) Biomarkers predicting malignant progression of laryngeal epithelial precursor lesions: a systematic review. Eur Arch Otorhinolaryngol 269:1073–1083
Patel KN (2013) Genetic mutations, molecular markers and future directions in research. Oral Oncol 49:711–721
Takebayashi S, Ogawa T, Jung KY, Muallem A, Mineta H, Fisher SG, Grenman R, Carey TE (2000) Identification of a new minimally lost regions on 18q in head and neck squamous cell carcinoma. Cancer Res 60:3397–3403
Kujawski M, Sarlomo-Rikala M, Gabriel A, Szyfter K, Knuutila S (1999) Recurrent DNA copy number losses associated with metastasis of larynx carcinoma. Genes Chromosomes Cancer 26:253–257
Singh B, Gogineni SK, Sacks PG, Shaha AR, Shah JP, Stoffel A, Rao PH (2001) Molecular cytogenetics characterization of head and neck squamous cell carcinoma and refinement of 3q amplification. Cancer Res 61:4506–4513
Speicher MR, Howe C, Crotty P, du Manoir S, Costa J, Ward DC (1995) Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinoma. Cancer Res 55:1010–1013
Järvinen AK, Autio R, Haapa-Paananen S, Wolf M, Saarela M, Grénman R, Leivo I, Kallioniemi O, Mäkitie AA, Monni O (2006) Identification of target genes in laryngeal squamous cell carcinoma by high-resolution copy number and gene expression microarray analyses. Oncogene 25:6997–7008
Hashimito Y, Oga A, Kawauchi S, Furuya T, Shimizu N, Nakano T, Imate Y, Yamashita H, Sasaki K (2001) Amplification of 3q26-qter correlates with tumor progression in head and neck squamous cell carcinomas. Cancer Genet Cytogenet 129:52–56
Riazimand SH, Welkoborsky HJ, Bernauer HS, Jacob R, Mann WJ (2002) Investigation for fine mapping of amplifications in chromosome 3q26.3-28 frequently occurring in squamous cell carcinomas of the head and neck. Oncology 63:385–392
Brieger J, Kastner J, Gosepath J, Mann WJ (2006) Evaluation of microsatellite amplification at chromosomal locus 3q26 as a surrogate marker for premalignant change in mucosa surrounding head and neck squamous cell carcinoma. Cancer Genet Cytogenet 167:26–31
Redon R, Muller D, Caulee K, Wanherdrick K, Abecassis J, du Manoir S (2001) A simple specific pattern of chromosomal aberration at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains. Cancer Res 61:4122–4129
Pedrero JMG, Carracedo DG, Pinto CM, Zapatero AH, Rodrigo JP, Nieto CS, Gonzalez MV (2005) Frequent genetic and biochemical alterations of the PI 3-K/AKT/PTEN pathway in head and neck carcinoma. Int J Cancer 114:242–248
Murugan AK, Munirajan AK, Tsuchida N (2013) Genetic deregulation of the PIK3CA oncogene in oral cancer. Cancer Lett 338:193–203
Sarkaria I, O-charoenrat P, Talbot SG, Reddy PG, Ngai I, Maghami E, Patel KN, Lee B, Yonekawa Y, Dudas M, Kaufman A, Ryan R, Ghossein R, Rao PH, Stoffel A, Ramanathan Y, Singh B (2006) Squamous cell carcinoma related oncogene/DCUN1D1 is highly conserved and activated by amplification in squamous cell carcinomas. Cancer Res 66:9437–9444
Virgilio L, Shuster M, Gollin SM, Veronese ML, Ohta M, Huebner K, Croce CM (1996) FHIT gene alterations in head and neck squamous cell carcinomas. Proc Nat Acad Sci USA 93:9770–9775
Iliopoulos D, Guler G, Han SY, Druck T, Ottey M, McCorkell KA, Huebner K (2006) Roles of FHIT and WWOX fragile genes in cancer. Cancer Lett 232:27–36
Sasiadek MM, Stembalska-Kozlowska A, Smigiel R, Ramsey D, Kayademir T, Blin N (2004) Impairment of MLH1 and CDKN2A in oncogenesis of laryngeal cancer. Br J Cancer 90:1594–1599
Sengupta S, Chakrabarti S, Roy A, Panda CK, Roychoudhury S (2007) Inactivation of human MutL homolog1 and MutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relations with microsatellite instability phenotype. Cancer 109:703–712
Wang J, Chen H, Fu S, Xu ZM, Sun KL, Fu WN (2011) The involvement of CHD5 hypermethylation in laryngeal squamous cell carcinomas. Oral Oncol 47:601–608
da Silva Veiga LC, Bérgamo NA, dos Reis PP, Kowalski LP, Rogatto SR (2003) DNA gains at 8q23.2: a potential early marker in head and neck carcinomas. Cancer Genet Cytogenet 146:110–115
Giefing M, Zemke N, Brauze D, Kostrzewska-Poczekaj M, Luczak M, Szaumkessel M, Pelinska K, Kiwerska K, Tönnies H, Grenman R, Figlerowicz M, Siebert R, Szyfter K, Jarmuz M (2011) High resolution array CGH and expression profiling identifies PTPRD and PCDH17/PCH68 as tumor suppressor gene candidates in laryngeal squamous cell carcinoma. Genes Chromosomes Cancer 50:154–166
Poetsch M, Lorenz G, Kleist B (2002) Detection of new PTEN/MMAC1 mutations in head and neck squamous cell carcinomas with loss of chromosome 10. Cancer Genet Cytogenet 132:20–24
Squarize CH, Castilho RM, Abrahao AC, Molinolo A, Lingen MW, Gutkind JS (2013) PTEN deficiency contributes to the development and progression of head and neck cancer. Neoplasia 15:461–471
Mriouah J, Boura C, Gargouri M, Plénat F, Faivre B (2014) PTEN expression is involved in the invasive properties of HNSCC: a key protein to consider in locoregional recurrence. Int J Oncol 44:709–716
Rodríguez MJ, Acha A, Ruesga MT, Rodríguez C, Rivera JM, Aguirre JM (2007) loss of expression of DNA repair enzyme MGMT in oral leukoplakia and early oral squamous cell carcinoma. A prognostic tool? Cancer Lett 245:263–268
Esteller M, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, Watkins DN, Issa JP, Sidransky D, Baylin SB, Herman JG (2000) Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res 60:2368–2371
Jarmuz-Szymczak M, Pelinska K, Kostrzewska-Poczekaj M, Bembnista E, Giefing M, Brauze D, Szaumkessel M, Marszalek A, Janiszewska A, Kiwerska K, Bartochowska A, Grenman R, Szyfter W, Szyfter K (2013) Heterogeneity of 11q13 region rearrangement in laryngeal squamous cell carcinoma analyzed by microarray platforms and fluorescence in situ hybridization. Mol Biol Rep 40:4161–4171
Jarmuż M, Grenman R, Golusinski W, Szyfter K (2005) Aberrations of 11q13 in laryngeal squamous cell lines and their prognostic significance. Cancer Genet Cytogenet 160:82–88
Mishra R (2013) Cell cycle-regulatory cyclins and their deregulation in oral cancer. Oral Oncol 49:475–481
Rodrigo JP, Garcia LA, Ramos S, Lazo PS, Suárez C (2000) EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck. Clin Cancer Res 6:3177–3182
Huang X, Gollin SM, Raja S, Godfrey TE (2002) High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells. Proc Nat Acad Sci USA 99:11369–11374
Ayoub C, Wasylyk C, Li Y, Thomas E, Marisa L, Robé A, Roux M, Abecassis J, de Reyniès A, Wasylyk B (2010) ANO1 amplification and expression in HNSCC with a high propensity for future distant metastasis and its functions in HNSCC cell lines. Br J Cancer 103:715–726
Pattje WJ, Melchers LJ, Slagter-Menkema L, Mastik MF, Schrijvers ML, Gibcus JH, Kluin PM, Hoegen-Chouvalova O, van der Laan BF, Roodenburg JL, van der Wal JE, Schuuring E, Langendijk JA (2013) FADD expression is associated with regional and distant metastasis in squamous cell carcinoma of the head and neck. Histopathology 63:263–270
Wilkerson PM, Reis-Filho JS (2013) The 11q13-q14 amplicon: clinicopathological correlation and potential drivers. Genes Chromosomes Cancer 52:333–355
Stembalska A, Blin N, Ramsey D, Sasiadek MM (2006) Three distinct regions of deletion on 13q in squamous cell carcinoma of the larynx. Oncol Rep 16:417–421
Gunduz M, Ouchida M, Fukushima K, Hanafusa H, Etani T, Nishioka S, Nishizaki K, Shimizu K (2000) Genomic structure of the human ING1 gene and tumor-specific mutations detected in head and neck squamous cell carcinoma. Cancer Res 60:3143–3146
Sivadas VP, George NA, Kattoor J, Kannan S (2013) Novel mutations and expression alterations in SMAD3/TGFBR2 genes in oral carcinoma correlate with poor prognosis. Genes Chromosomes Cancer 52:1042–1052
Gomes MG, Diniz GG, Oliveira CS, Tavassoli M, Odell EW, Gomez RS, De Marco L (2011) Impact of WWOX alterations on p73, ΔNp73, p53, cell proliferation and DNA ploidy in salivary gland neoplasms. Oral Dis 17:564–571
Rothenberg SM, Ellisen LW (2012) The molecular pathogenesis of head and neck squamous cell carcinoma. J Clin Invest 122:1951–1957
Tandon S, Tudur-Smith C, Riley RD, Boyd MT, Jones TM (2010) A systematic review of p53 as a prognostic factor of survival in squamous cell carcinoma of the four main anatomical subsites of the head and neck. Cancer Epidemiol Biomarkers Prev 19:574–587
Tassone P, Old M, Teknos TN, Pan Q (2013) p53-based therapeutics for head and neck squamous cell carcinoma. Oral Oncol 49:733–737
Li Y, Chen Z (2004) Molecular cloning and characterization of LCRG1, a novel gene localized to the tumor suppressor locus D17S800-D17S930. Cancer Lett 209:75–85
Zhang X, Xiao Z, Chen Z, Li C, Li J, Yanhui Y, Yang F, Oyang Y, Yang YX (2006) Comparative proteomics analysis of the proteins associated with laryngeal carcinoma-related gene 1. Laryngoscope 116:224–230
Qiu W, Schönleben F, Thaker HM, Goggins M, Su GH (2006) A novel mutation of STK11/LKB1 gene leads to the loss of cell growth in head and neck squamous cell carcinoma. Oncogene 25:2937–2942
Ohta M, Mimori K, Fukuyoshi Y, Kita Y, Motoyama K, Yamashita K, Ishii H, Inoue H, Mori M (2008) Clinical significance of the reduced expression of G protein gamma 7 (GNG7) in oesophageal cancer. Br J Cancer 98:410–417
Hartmann S, Szaumkessel M, Salaverria I, Simon R, Sauter G, Kiwerska K, Gawecki W, Bodnar M, Marszalek A, Richter J, Brauze D, Zemke N, Jarmuz M, Hansmann ML, Siebert R, Szyfter K, Giefing M (2012) Loss of protein expression and recurrent DNA hypermethylation of the GNG7 gene in squamous cell carcinoma of the head and neck. J Appl Genet 53:167–174
Wu X, Cao W, Wang X, Zhang J, Qin X, Lv Z, Wu Y, Chen W (2013) TGM3, a candidate tumor suppressor gene, contributes to human head and neck cancer. Mol Cancer 12:151
Kostrzewska-Poczekaj M, Gieging M, Jarmuz M, Brauze D, Pelinska K, Grenman R, Bartochowska A, Szyfter W, Szyfter K (2010-2011) Recurrent amplification in the 22q11 region in laryngeal squamous cell carcinoma results in overexpression of the CRKL but not the MAPK1 oncogene. Cancer Biomark 8:11–19
Rettori MM, de Carvalho AC, Bomfim Longo AL, de Oliveira CZ, Kowalski LP, Carvalho AP, Vettore AL (2013) Prognostic significance of TIMP3 hypermethylation in post-treatment salivary rinse from head and neck squamous cell carcinoma patients. Carcinogenesis 34:20–27
Worsham MJ, Chen KM, Meduri V, Nygren AOH, Errami A, Schouten JP, Benninger MS (2006) Epigenetic events of disease progression in head and neck squamous cell carcinoma. Acta Otolaryngol Head Neck Surg 132:668–677
Baba S, Yamada Y, Hatano Y, Miyazaki Y, Mori H, Shibata T, Hara A (2009) Global DNA hypomethylation suppresses squamous carcinogenesis in the tongue and esophagus. Cancer Sci 100:1186–1191
Paluszczak J, Misiak P, Wierzbicka M, Woźniak A, Baer-Dubowska W (2011) Frequent hypermethylation of DAPK, RARbeta, MGMT, RASSF1A and FHIT in laryngeal squamous cell carcinomas and adjacent normal mucosa. Oral Oncol 47:104–107
Dikshit RP, Gillio-Tos A, Brennan P, De Marco L, Fiano V, Martinez-Peñuela JM, Boffetta P, Merletti F (2007) Hypermethylation, risk factors, clinical characteristics, and survival in 235 patients with laryngeal and hypopharyngeal cancers. Cancer 110:1745–1751
Wang F, Song G, Liu M, Li X, Tang H (2011) miRNA-1 targets fibronectin1 and suppresses the migration and invasion of the HEp2 laryngeal squamous carcinoma cell line. FEBS Lett 585:3263–3269
Hendrix A, Westbroek W, Bracke M, De Wever O (2010) An Ex(o)citing machinery for invasive tumor growth. Cancer Res 70:9533–9537
Luo X, Fan S, Huang W, Zhai S, Ma Z, Li P, Sun SY, Wang X (2012) Downregulation of IRS-1 promotes metastasis of head and neck squamous cell carcinoma. Oncol Rep 28:659–667
Yan J, Huang Q (2012) Genomics screens for metastasis genes. Cancer Metastasis Rev 31:419–428
Schaaij-Visser TBM, Graveland AP, Gauci S, Braakhuis BJM, Buijze M, Heck AJR, Kuik DJ, Bloemena E, Leemans CR, Slijper M, Brakenhoff RH (2009) Differential proteomic identifies protein biomarkers that predict local relapse of head and neck squamous cell carcinomas. Clin Cancer Res 15:7666–7675
Gutiérrez VF, Marcos CÁ, Llorente JL, Guervós MA, Iglesias FD, Tamargo LA, Hermsen M (2012) Genetic profile of second primary tumors and recurrences in head and neck squamous cell carcinomas. Head Neck 34:830–839
Glazer CA, Chang SS, Ha PK, Califano JA (2009) Applying the molecular biology and epigenetics of head and neck cancer in everyday clinical practice. Oral Oncol 45:440–446
Knudsen ES, Wang JY (2010) Targeting the RB-pathway in cancer therapy. Clin Cancer Res 16:1094–1099
Author information
Authors and Affiliations
Corresponding author
Additional information
This paper was written by members of the International Head and Neck Scientific Group (http://www.IHNSG.com).
Rights and permissions
About this article
Cite this article
Szyfter, K., Wierzbicka, M., Hunt, J.L. et al. Frequent chromosomal aberrations and candidate genes in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 273, 537–545 (2016). https://doi.org/10.1007/s00405-014-3339-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-014-3339-1